December 6, 2019 -- How is the use of artificial intelligence (AI) changing the interpretation of Digital Breast Tomosynthesis (DBT) exams? In this video from RSNA 2019, Rodney Hawkins, vice president of product management for iCAD, discusses the advantages of using ProFound AI for Digital Breast Tomosynthesis, the first and only FDA-cleared software for DBT with AI.
The move from 2D to 3D mammography offers major benefits in terms of improved detection of breast cancer. But 3D mammography also creates new challenges for breast centers, especially given the much higher data volumes that must be analyzed -- leading to longer study interpretation times. But ProFound AI for DBT can help.